M
Montinutra
Produces high value bioactive products from forest industry side streams
About Montinutra
Montinutra, which is newly branded as Boreal Bioproducts®, is a Finnish B2B company founded in 2018, operating at the intersection of the bioeconomy and circular economy. The firm is focused on upcycling underutilized side streams from the forest industry, such as sawdust and bark, into high-value, sustainable biochemicals. This approach directly challenges the chemical and cosmetics industries' reliance on fossil-based raw materials. The company's current CEO is Jaakko Pajunen, who brought over 15 years of experience in business development and the circular economy, including a role as Development Director at Lassila & Tikanoja, when he took the helm in January 2022.
The core of Montinutra's operation is a proprietary production process based on pressurized hot water extraction (PHWE). This method avoids the use of chemical solvents, enabling a robust, zero-waste, and cost-effective production of natural fractions with a minimal environmental footprint. By transforming forestry by-products, the company provides a scalable, bio-based alternative to fossil-derived materials without interfering with the food production chain. Their business model centers on creating value from these existing resources, ensuring a steady, year-round supply of certified and renewable feedstock.
The product portfolio, marketed under the Boreal Bioproducts® brand, includes a range of natural, vegan, and biodegradable ingredients. These biochemicals, such as SpruceSugar™ (polysaccharides) and SpruceLigno™ (lignins), serve diverse applications including industrial binders, barrier coatings, dispersants, and personal care products. For the cosmetics sector, the ingredients offer functionalities like film-forming, SPF-boosting, and anti-aging properties. After securing €2 million in a pre-A funding round led by Metsä Spring in late 2023, Montinutra is accelerating its international expansion and the development of an industrial demo plant, which is planned to be operational by 2026. The company's long-term ambition is to achieve an annual revenue of 100 million euros by 2035.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Raisio, Finland
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Metsa Spring
Business Finland
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Montinutra on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Montinutra on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.